CoChat

SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma

Open access
Kim, Yun Hak, Jeong, Dae Cheon, Pak, Kyoungjune, Han, Myoung-Eun, Kim, Ji-Young, Liangwen, Liu, Kim, Hyun Jin, Kim, Tae Woo, Kim, Tae Hwa, Hyun, Dong Woo, Oh, Sae-Ock · 2017 · Oncotarget
Cited by 102

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

// Yun Hak Kim 1, * , Dae Cheon Jeong 2, * , Kyoungjune Pak 3 , Myoung-Eun Han 1 , Ji-Young Kim 1 , Liu Liangwen 1 , Hyun Jin Kim 4 , Tae Woo Kim 5 , Tae Hwa Kim 6 , Dong Woo Hyun 7 and Sae-Ock Oh 1 1 Department of Anatomy, School of medicine, Pusan National University, Yangsan, Republic of Korea 2 Department of Statistics, Korea University, Seoul 02841, Republic of Korea 3 Department of Nuclear Medicine, Pusan National University Hospital, Busan, Republic of Korea 4 Eco-friendly new materials research center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea 5 Department of Orthopaedic Surgery, Pusan National University Hospital, Yangsan, Republic of Korea 6 Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea 7 Department of General Surgery, Pusan National University Hospital, Busan, Republic of Korea * These authors contributed equally to this work Correspondence to: Sae-Ock Oh, email: hedgehog@pusan.ac.kr Keywords: hepatocellular carcinoma (HCC), solute carrier 2A (SLC2A), glucose transporter (GLUT), the cancer genome atlas (TCGA), 2- 18 fluoro-deoxy-D-glucose ( 18 FDG) Received: June 10, 2017 Accepted: July 25, 2017 Published: August 14, 2017 ABSTRACT High rates of glucose transport via solute carrier (SLC2A, GLUT) family members are required to satisfy the high metabolic demands of cancer cells, and because of this characteristic of cancer cells 2- 18 fluoro-deoxy-D-glucose ( 18 FDG)-PET has become a powerful diagnostic tool. However, its sensitivity for hepatocellular carcinoma (HCC) is lower than for other malignancies, which suggests SLC2A family members are differentially expressed in HCC. In the present study, the expression patterns of SLC2A family members in tumor tissues and their associations with HCC progression were analyzed using data obtained from The Cancer Genome Atlas (TCGA). It was found that the expression of SLC2A2 (GLUT2) was higher in HCC than those of other members of the SLC2A family. The associations of the expression levels of SLC2A family members and previously known prognostic factors with clinical stages were examined using the T -test or the Mann-Whitney U test, and interestingly, SLC2A2 expression was found to be associated with an advanced clinical stage ( p = 0.0015). Furthermore, Kaplan-Meier analysis using the log-rank or the Gehan-Breslow-Wilcoxon test showed SLC2A2 expression was positively associated with overall survival ( p < 0.001, Gehan-Breslow-Wilcoxon test and p = 0.0145 by multivariate Cox regression). The prognostic significance of SLC2A2 was similar in both early and late stages. However, it was more significant in HCC patients without alcohol consumption history and hepatitis C infection. Taken together, SLC2A2 was associated with clinical stages and independently associated with overall survival in patients with HCC. We suggest that SLC2A2 be considered a new prognostic factor for HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.20266

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 102

Metadata

Authors
Kim, Y. H., Jeong, D. C., Pak, K., Han, M.-E., Kim, J.-Y., Liangwen, L., Kim, H. J., Kim, T. W., Kim, T. H., Hyun, D. W., & Oh, S.-O.
Venue
Oncotarget
Published
2017-08-14
Volume
8
Issue
40
Pages
68381-68392
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2748071788
Cited by
102
References
11
FWCI
5.24
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.20266
The paper
Kim, Y. H., Jeong, D. C., Pak, K., Han, M.-E., Kim, J.-Y., Liangwen, L., Kim, H. J., Kim, T. W., Kim, T. H., Hyun, D. W., & Oh, S.-O. (2017). SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.20266

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.